Literature DB >> 17870037

The course of established rheumatoid arthritis.

David L Scott1, Sophia Steer.   

Abstract

Rheumatoid arthritis (RA) varies over time in individual patients and there are marked differences between patients in its impact and progression. The course of RA is therefore unique to each individual patient and is affected by the overall pattern of disease; many patients have classical polyarticular disease but there is also a range of subtypes, such as fibromyalgic and polymyalgic disease. Some patients with RA enter a period of sustained remission; this varies between 10% and 36% of cases; its frequency is mainly influenced by the different approaches to studying RA patients over time, and does not represent a true difference in disease outcome. Most patients have persisting synovial inflammation and disease activity scores average between 3 and 4; there is some evidence that inflammation is less marked in late RA. Persisting synovitis results in increasing disability - this worsens by an average of 0.6% each year - and in joint damage, which increases by an average of 2% each year. Comorbidities and extra-articular features are commonplace: about one-third of patients, respectively, have associated cardiovascular disease, lung disease or extra-articular features, although severe extra-articular problems like vasculitis affect only about 10% of patients. Some aspects of the course of RA are influenced by genetic risks; currently these are only weak predictors but it is anticipated their value will increase with time.

Entities:  

Mesh:

Year:  2007        PMID: 17870037     DOI: 10.1016/j.berh.2007.05.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  24 in total

Review 1.  Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Iñigo Bermejo; Shijie Ren; Emma Simpson; Mark Clowes; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

2.  The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Piercarlo Sarzi-Puttini
Journal:  Rheumatol Int       Date:  2018-06-28       Impact factor: 2.631

3.  Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.

Authors:  Xiaoyan Zhao; Ferhan Qureshi; P Scott Eastman; William C Manning; Claire Alexander; William H Robinson; Lyndal K Hesterberg
Journal:  J Immunol Methods       Date:  2012-02-17       Impact factor: 2.303

4.  Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial.

Authors:  Louise Larkin; Stephen Gallagher; Alexander Fraser; Norelee Kennedy
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

Review 5.  Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Iñigo Bermejo; Matt Stevenson; Rachel Archer; John W Stevens; Edward Goka; Mark Clowes; David L Scott; Adam Young
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

Review 6.  Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Lesley Uttley; Iñigo Bermejo; Shijie Ren; Marrissa Martyn-St James; Ruth Wong; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

7.  Elbow pain proven to be tuberculous arthritis -A case report-.

Authors:  Sun Soph Jung; Mi Kyoung Lee; Sang Ho Lim; Yong-Man Kwon; Sang-Sik Choi
Journal:  Korean J Anesthesiol       Date:  2010-02-28

Review 8.  Motivational interviewing: relevance in the treatment of rheumatoid arthritis?

Authors:  Sofia Georgopoulou; Louise Prothero; Heidi Lempp; James Galloway; Jackie Sturt
Journal:  Rheumatology (Oxford)       Date:  2015-10-28       Impact factor: 7.580

9.  Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy.

Authors:  Sarah Hewlett; Nick Ambler; Celia Almeida; Alena Cliss; Alison Hammond; Karen Kitchen; Bev Knops; Denise Pope; Melissa Spears; Annette Swinkels; Jon Pollock
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

Review 10.  Effects of rehabilitation for pain relief in patients with rheumatoid arthritis: a systematic review.

Authors:  Youngju Park; Moonyoung Chang
Journal:  J Phys Ther Sci       Date:  2016-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.